TABLE 3.
Revised El Escorial criteria | N | pNfL Median (IQR) | N | cNfL Median (IQR) |
Possible ALS | 38 | 64.9 (27.6–101.3) | 25 | 4536 (2232–8853) |
Probable laboratory-supported ALS | 31 | 45.8 (31.4–70.7) | 24 | 5100 (3145.2–7760) |
Probable ALS | 68 | 86.1 (57.7–127.2) | 45 | 7572 (4770–15569) |
Definite ALS | 31 | 100.5 (58.8–135.5) | 19 | 10892.4 (6156–14629) |
Genetic status | N | pNfL Median (IQR) | N | cNfL Median (IQR) |
Wild-type | 137 | 73.5 (43.9–113.7) | 98 | 6317 (3574–13476) |
SOD1 | 6 | 36.0 (14.0–59.4) | 2 | 2252; 4536 |
TARDBP | 2 | 32.8; 51.8 | 1 | 3018.5 |
FUS | 1 | 37.2 | 0 | NA |
C9Orf72 | 18 | 107.1 (64.5–125.3) | 11 | 10796 (7950–12031) |
Biomarker values are expressed in pg/ml. Key: ALS, amyotrophic lateral sclerosis; cNfL, cerebrospinal neurofilament light chain; IQR, interquartile range; N, number; NA, not available; pNfL, plasma neurofilament light chain.